Biological processes revealed in the HER2+ and TN subtypes included “vascular endothelial cell proliferation” and “stress granule assembly” (Fig. 5), while the HER2+ and HR+ subtypes showed a dysregulation of “Titin binding”, all of which are involved in tumorigenesis of breast cancers [42–44]. The gene discussed is ERBB2; the disease is breast cancer.